Engerix-B

Engerix-B is a vaccine designed to prevent hepatitis B infection. It contains hepatitis B surface antigen (rDNA) and alum as an adjuvant. This vaccine is suitable for individuals at risk of hepatitis B exposure.

Engerix-B is used to protect against hepatitis B virus infection. It is commonly administered to individuals who may be at risk due to occupational exposure, travel to endemic areas, or other high-risk situations. The vaccine works by stimulating the body's immune response to develop protection against the virus.

Common effects of Engerix-B may include soreness at the injection site, mild fever, and fatigue. These effects are typically mild and short-lived. Severe reactions are rare but can occur, and medical attention should be sought if they do.

Engerix-B should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to previous doses or components of the vaccine should avoid it. It is important to inform the healthcare provider of any medical conditions or allergies before receiving the vaccine.

Engerix-B may interact with certain medications or medical conditions. It is important to discuss all current medications and health conditions with a healthcare provider before receiving the vaccine. Alcohol and other immune-suppressing substances may affect the vaccine's effectiveness.